Harris & Harris Group (TURN) Competitors $4.58 +0.01 (+0.11%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TURN vs. BIOX, FLD, SPKL, EVE, FSP, JYNT, PRPB, RFAI, FSNB, and ROSSShould you be buying Harris & Harris Group stock or one of its competitors? The main competitors of Harris & Harris Group include Bioceres Crop Solutions (BIOX), Fold (FLD), Spark I Acquisition (SPKL), EVe Mobility Acquisition (EVE), Franklin Street Properties (FSP), Joint (JYNT), CC Neuberger Principal Holdings II (PRPB), RF Acquisition Corp II (RFAI), Fusion Acquisition Corp. II (FSNB), and Ross Acquisition Corp II (ROSS). These companies are all part of the "trading" industry. Harris & Harris Group vs. Its Competitors Bioceres Crop Solutions Fold Spark I Acquisition EVe Mobility Acquisition Franklin Street Properties Joint CC Neuberger Principal Holdings II RF Acquisition Corp II Fusion Acquisition Corp. II Ross Acquisition Corp II Bioceres Crop Solutions (NASDAQ:BIOX) and Harris & Harris Group (NASDAQ:TURN) are both small-cap trading companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk. Which has higher valuation and earnings, BIOX or TURN? Bioceres Crop Solutions has higher revenue and earnings than Harris & Harris Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioceres Crop Solutions$464.80M0.37$3.24M-$0.14-19.71Harris & Harris Group$190K241.32-$3.87MN/AN/A Does the media favor BIOX or TURN? In the previous week, Harris & Harris Group had 6 more articles in the media than Bioceres Crop Solutions. MarketBeat recorded 8 mentions for Harris & Harris Group and 2 mentions for Bioceres Crop Solutions. Bioceres Crop Solutions' average media sentiment score of 0.55 beat Harris & Harris Group's score of 0.25 indicating that Bioceres Crop Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioceres Crop Solutions 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Harris & Harris Group 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is BIOX or TURN more profitable? Harris & Harris Group has a net margin of 0.00% compared to Bioceres Crop Solutions' net margin of -2.14%. Harris & Harris Group's return on equity of 0.00% beat Bioceres Crop Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Bioceres Crop Solutions-2.14% -2.37% -0.99% Harris & Harris Group N/A N/A N/A Do analysts rate BIOX or TURN? Bioceres Crop Solutions currently has a consensus target price of $8.38, indicating a potential upside of 203.44%. Given Bioceres Crop Solutions' stronger consensus rating and higher probable upside, equities research analysts plainly believe Bioceres Crop Solutions is more favorable than Harris & Harris Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioceres Crop Solutions 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Harris & Harris Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in BIOX or TURN? 17.7% of Bioceres Crop Solutions shares are held by institutional investors. Comparatively, 19.8% of Harris & Harris Group shares are held by institutional investors. 11.8% of Harris & Harris Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, BIOX or TURN? Bioceres Crop Solutions has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500. Comparatively, Harris & Harris Group has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500. SummaryHarris & Harris Group beats Bioceres Crop Solutions on 8 of the 14 factors compared between the two stocks. Get Harris & Harris Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TURN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TURN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TURN vs. The Competition Export to ExcelMetricHarris & Harris GroupENGINRG/R&D SVS IndustryConstruction SectorNASDAQ ExchangeMarket Cap$45.85M$6.70B$9.40B$9.53BDividend YieldN/A1.21%1.87%4.09%P/E RatioN/A21.2015.8724.79Price / Sales241.3214.73122.9896.24Price / CashN/A16.9515.1859.16Price / BookN/A5.334.736.18Net Income-$3.87M$341.50M$618.69M$265.56M7 Day Performance3.97%-3.25%-2.52%-2.33%1 Month Performance12.10%-8.76%4.64%0.12%1 Year Performance35.65%35.01%102.29%19.82% Harris & Harris Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TURNHarris & Harris GroupN/A$4.59+0.1%N/A+36.7%$45.85M$190K0.007Positive NewsShort Interest ↓BIOXBioceres Crop Solutions2.654 of 5 stars$2.94-2.0%$8.38+184.9%-71.1%$184.37M$383.29M-21.00500FLDFold2.1439 of 5 stars$3.90+6.0%$7.83+100.9%N/A$180.88MN/A0.00N/ASPKLSpark I AcquisitionN/A$11.000.0%N/A+4.9%$180.56MN/A0.00N/ANews CoveragePositive NewsShort Interest ↓EVEEVe Mobility AcquisitionN/A$11.27flat$5.00-55.6%N/A$175.77MN/A0.004FSPFranklin Street Properties1.5422 of 5 stars$1.67+2.8%N/A+5.7%$172.64M$111.88M-3.3330JYNTJoint3.9245 of 5 stars$10.47-0.8%$16.33+56.0%-10.9%$160.64M$53.45M-31.73320Insider TradePRPBCC Neuberger Principal Holdings IIN/A$1.93+6.6%N/A-43.9%$159.80MN/A0.004RFAIRF Acquisition Corp IIN/A$10.61+0.0%N/A+5.1%$159.18MN/A0.00N/APositive NewsFSNBFusion Acquisition Corp. IIN/A$10.49flatN/AN/A$154.10MN/A0.002High Trading VolumeROSSRoss Acquisition Corp IIN/A$11.08flatN/AN/A$151.46MN/A0.003High Trading Volume Related Companies and Tools Related Companies Bioceres Crop Solutions Competitors Fold Competitors Spark I Acquisition Competitors EVe Mobility Acquisition Competitors Franklin Street Properties Competitors Joint Competitors CC Neuberger Principal Holdings II Competitors RF Acquisition Corp II Competitors Fusion Acquisition Corp. II Competitors Ross Acquisition Corp II Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TURN) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harris & Harris Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harris & Harris Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access